FI92065C - Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksiInfo
- Publication number
- FI92065C FI92065C FI886057A FI886057A FI92065C FI 92065 C FI92065 C FI 92065C FI 886057 A FI886057 A FI 886057A FI 886057 A FI886057 A FI 886057A FI 92065 C FI92065 C FI 92065C
- Authority
- FI
- Finland
- Prior art keywords
- pharmaceutical
- preparation
- piperidine derivatives
- piperidine
- derivatives
- Prior art date
Links
- 150000003053 piperidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13989987 | 1987-12-31 | ||
| US07/139,899 US4791120A (en) | 1987-12-31 | 1987-12-31 | 4-heteropentacyclic-4-[N-(phenyl)amino] piperidine derivatives and pharmaceutical compositions and method employing such compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI886057A FI886057A (fi) | 1989-07-01 |
| FI92065B FI92065B (fi) | 1994-06-15 |
| FI92065C true FI92065C (fi) | 1994-09-26 |
Family
ID=22488798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI886057A FI92065C (fi) | 1987-12-31 | 1988-12-30 | Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4791120A (fi) |
| JP (1) | JPH01213278A (fi) |
| KR (1) | KR890009921A (fi) |
| CN (1) | CN1023010C (fi) |
| AU (1) | AU616708B2 (fi) |
| DK (1) | DK732888A (fi) |
| FI (1) | FI92065C (fi) |
| IL (1) | IL88645A (fi) |
| NO (1) | NO174553C (fi) |
| NZ (1) | NZ227172A (fi) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871749A (en) * | 1987-12-31 | 1989-10-03 | Boc, Inc. | 4-heteropentacyclic-4-(N-(phenyl)amido) piperidine derivatives and pharamaceutical compositions and method employing such compounds |
| US5145967A (en) * | 1989-04-20 | 1992-09-08 | Anaquest, Inc. | Method for preparing 4-alkoxyalkyl-4-phenylaminopiperdines and derivatives thereof |
| USRE34201E (en) * | 1989-04-20 | 1993-03-23 | Anaquest, Inc. | N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds |
| US5053411A (en) * | 1989-04-20 | 1991-10-01 | Anaquest, Inc. | N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds |
| FR2725986B1 (fr) * | 1994-10-21 | 1996-11-29 | Adir | Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6635661B2 (en) | 2000-05-25 | 2003-10-21 | Sepracor Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US7361666B2 (en) * | 1999-05-25 | 2008-04-22 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US6677332B1 (en) | 1999-05-25 | 2004-01-13 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US6376514B1 (en) | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
| US6693099B2 (en) * | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| AU2003277552A1 (en) * | 2002-11-06 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor regulator |
| AU2006317591A1 (en) * | 2005-11-17 | 2007-05-31 | Mallinckrodt Inc. | Process for synthesizing remifentanil |
| RU2612970C1 (ru) * | 2015-10-05 | 2017-03-14 | Федеральное государственное казённое военное образовательное учреждение высшего профессионального образования "Военная академия радиационной, химической и биологической защиты имени Маршала Советского Союза С.К. Тимошенко" г. Кострома Министерства обороны Российской Федерации | Способ получения 1-бензил-4-пропиоанилидо-4-пиперидинкарбонитрила |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE623427A (fi) * | 1961-10-10 | |||
| US3998834A (en) * | 1975-03-14 | 1976-12-21 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl)-n-phenylamides and -carbamates |
| US4584303A (en) * | 1984-04-09 | 1986-04-22 | The Boc Group, Inc. | N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds |
-
1987
- 1987-12-31 US US07/139,899 patent/US4791120A/en not_active Expired - Fee Related
-
1988
- 1988-12-02 NZ NZ227172A patent/NZ227172A/en unknown
- 1988-12-06 AU AU26604/88A patent/AU616708B2/en not_active Ceased
- 1988-12-08 NO NO885463A patent/NO174553C/no unknown
- 1988-12-09 IL IL88645A patent/IL88645A/xx unknown
- 1988-12-28 JP JP63332752A patent/JPH01213278A/ja active Pending
- 1988-12-30 KR KR1019880018227A patent/KR890009921A/ko not_active Application Discontinuation
- 1988-12-30 FI FI886057A patent/FI92065C/fi not_active IP Right Cessation
- 1988-12-30 DK DK732888A patent/DK732888A/da not_active Application Discontinuation
- 1988-12-30 CN CN89100056A patent/CN1023010C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01213278A (ja) | 1989-08-28 |
| DK732888A (da) | 1989-07-01 |
| AU616708B2 (en) | 1991-11-07 |
| NO174553B (no) | 1994-02-14 |
| CN1023010C (zh) | 1993-12-08 |
| NZ227172A (en) | 1990-06-26 |
| NO885463D0 (no) | 1988-12-08 |
| NO885463L (no) | 1989-07-03 |
| DK732888D0 (da) | 1988-12-30 |
| CN1035285A (zh) | 1989-09-06 |
| AU2660488A (en) | 1989-07-13 |
| FI92065B (fi) | 1994-06-15 |
| KR890009921A (ko) | 1989-08-04 |
| IL88645A (en) | 1993-07-08 |
| US4791120A (en) | 1988-12-13 |
| NO174553C (no) | 1994-05-25 |
| FI886057A (fi) | 1989-07-01 |
| IL88645A0 (en) | 1989-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI874459A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi | |
| FI92934B (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi | |
| FI885884A0 (fi) | Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi | |
| FI882007A (fi) | Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi | |
| FI893520A (fi) | Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi | |
| FI890282A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
| FI892640A0 (fi) | Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
| FI892182A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi | |
| PT86687A (pt) | Process for the preparation of novel polyamine derivatives | |
| FI98830B (fi) | Menetelmä bifunktionaalisten proteiinien valmistamiseksi | |
| FI90430C (fi) | Menetelmä 2-substituoitujen adenosiinijohdannaisten valmistamiseksi | |
| PT87153A (pt) | Process for the preparation of acid ribofuranuronic derivatives | |
| FI93215C (fi) | Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi | |
| FI92065C (fi) | Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi | |
| FI884910A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi | |
| FI873350A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| FI884471A0 (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
| FI93106C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi | |
| FI892948A (fi) | Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi | |
| FI893003A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi | |
| FI895983A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi | |
| PT87024A (pt) | Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same | |
| FI93107B (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-imino-6-polyfluorialkoksibentsotiatsolijohdannaisten valmistamiseksi | |
| FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
| PT88681A (pt) | A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: BOC, INC. |